“We have been pioneers in bringing CBD to Finland, as well as to many other countries across Europe,” said Blake Schroeder, CEO of Kannaway. “We knew our operations and sales were legal in Finland, but receiving this ruling from the Finnish Supreme Administrative Court is very promising for the future of our company and the entire industry. We are on our way to becoming the world’s first truly global cannabis company.”
In 2018, Finnish customs confiscated a bottle Kannaway® Pure Gold He claimed it had been imported illegally since the Finnish Medicines Agency, FIMEA, listed CBD as a medicinal ingredient, causing the Finnish customs authority to take a “holistic approach” to treating all CBD products like medicines. On Friday, October 22, 2021, the Finnish Supreme Administrative Court declared that any product, in accordance with EU directives, should be classified as a medicinal product on a case-by-case basis with specific claims regarding therapeutic effects, dosage and support. Guide. In this case, the Supreme Administrative Court declared Kannaway® Pure Gold hemp oil not to be a medicinal product.
“This is a huge victory for Kannaway. Of course, the European cannabis industry will also benefit, but we are proud that our company took action, fought the battle and won. We hope this sets an important precedent for other EU jurisdictions,” said Kannaway, Managing Director of International Janne Heimonen. Where national medical agencies have had a similar view.” “We have been struggling for many years now to prove that we are not, by law, selling drugs, but our CBD oil is a dietary supplement.”
Kannawi® is a network sales and marketing company specializing in the sale and marketing of plant based cannabis products. Currently, Kannaway® hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity for sales professionals who wish to become successful leaders in the sale and marketing of plant-based, hemp-based products.
About Medical Marijuana, Inc.
We are Firsts® شركة. Medical Marijuana, Inc. (MJNA) is a cannabis company comprising three distinct business units in the non-psychoactive cannabis space: a global group of cannabis-based food brands led by Kannawi® And HempMeds®; A leader in sourcing high-quality legal, non-psychoactive cannabis products derived from industrial hemp; and the sector of cannabis-based clinical research and development of botanical medicines led by pharmaceutical investment companies and their partners including AXIM® Biotechnologies, Inc. And Neuropathics. Medical Marijuana, Inc. was selected. As the best CBD product ever CNBC. Medical Marijuana, Inc. Also the first company to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a pioneer in developing international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To watch a video of Medical Marijuana, Inc. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor law created by those sections. This material contains statements about expected future events and/or financial results of a forward-looking nature and subject to risks and uncertainties. These forward-looking statements by definition include risks, uncertainties and other factors, which could cause Medical Marijuana, Inc.’s actual results, performance or achievements to differ. materially from the data contained herein.
Disclosure by the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not. Selling or distributing any products that violate the Controlled Substances Act in the United States.
Public Relations Contact:
Investor Relations Contact:
p. (858) 283-4016